Patents by Inventor C. Dutt

C. Dutt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9199575
    Abstract: A lamp assembly for illuminating an exterior portion of a vehicle includes a lamp housing, and a switch supported by the lamp housing. The lamp assembly includes a flexible lens that is supported by the lamp housing and flexes to move relative to the lamp housing between an undepressed position and a depressed position when a force is applied to the lens. The lens is configured to cause the switch to move from a first position to a second position when the lens moves to the depressed position.
    Type: Grant
    Filed: November 27, 2013
    Date of Patent: December 1, 2015
    Assignee: GM Global Technology Operations LLC
    Inventors: Jay H. Ovenshire, Stanley C. Dutt
  • Publication number: 20150146444
    Abstract: A lamp assembly for illuminating an exterior portion of a vehicle includes a lamp housing, and a switch supported by the lamp housing. The lamp assembly includes a flexible lens that is supported by the lamp housing and flexes to move relative to the lamp housing between an undepressed position and a depressed position when a force is applied to the lens. The lens is configured to cause the switch to move from a first position to a second position when the lens moves to the depressed position.
    Type: Application
    Filed: November 27, 2013
    Publication date: May 28, 2015
    Applicant: GM GLOBAL TECHNOLOGY OPERATIONS LLC
    Inventors: Jay H. Ovenshire, Stanley C. Dutt
  • Patent number: 8378118
    Abstract: The present invention discloses a novel thyroid like compounds of formula (I), wherein R1 R2, R3, R4 and Z are as defined in the specification, method for its preparation, composition containing such compounds and use of such compounds and composition as medicament. Further, compounds of formula (I) has significantly low binding affinity to thyroid receptors and thus considerably devoid of thyrotoxic effects. The invention also relates to the use of the compound of formula (I) for the preparation of a medicament for treating various disease conditions such as obesity, dyslipidemia, metabolic syndrome and co-morbidities associated with metabolic syndrome.
    Type: Grant
    Filed: January 10, 2012
    Date of Patent: February 19, 2013
    Assignee: Torrent Pharmaceuticals Ltd.
    Inventors: Laxmikant Chhipa, Shitalkumar Pukharaj Zambad, Ramesh Gupta, Davinder Tuli, Ashok Kasundra, Siralee Munshi, M. Amir Siddiqui, Subrat Kumar Bhattamisra, C. Dutt, Vijay Chauthaiwale
  • Publication number: 20120202816
    Abstract: The present invention discloses a novel thyroid like compounds of formula (I), wherein R1 R2, R3, R4 and Z are as defined in the specification, method for its preparation, composition containing such compounds and use of such compounds and composition as medicament. Further, compounds of formula (I) has significantly low binding affinity to thyroid receptors and thus considerably devoid of thyrotoxic effects. The invention also relates to the use of the compound of formula (I) for the preparation of a medicament for treating various disease conditions such as obesity, dyslipidemia, metabolic syndrome and co-morbidities associated with metabolic syndrome.
    Type: Application
    Filed: January 10, 2012
    Publication date: August 9, 2012
    Applicant: Torrent Pharmaceuticals, Ltd.
    Inventors: Laxmikant Chhipa, Shitalkumar Pukharaj Zambad, Ramesh Gupta, Davinder Tuli, Ashok Kasundra, Siralee Munshi, M. Amir Siddiqui, Subrat Kumar Bhattamisra, C. Dutt, Vijay Chauthaiwale
  • Publication number: 20100168110
    Abstract: The present invention discloses a novel thyroid like compounds of formula (I), wherein R1 R2, R3, R4 and Z are as defined in the specification, method for its preparation, composition containing such compounds and use of such compounds and composition as medicament. Further, compounds of formula (I) has significantly low binding affinity to thyroid receptors and thus considerably devoid of thyrotoxic effects. The invention also relates to the use of the compound of formula (I) for the preparation of a medicament for treating various disease conditions such as obesity, dyslipidemia, metabolic syndrome and co-morbidities associated with metabolic syndrome.
    Type: Application
    Filed: June 2, 2008
    Publication date: July 1, 2010
    Applicant: TORRENT PHARMACEUTICALS LTD.
    Inventors: Laxmikant Chhipa, Shitalkumar Zambad, Ramesh Gupta, Davinder Tuli, Ashok Kasundra, Siralee Munshi, M. Amir Siddiqui, Subrat Kumar Bhattamisra, C. Dutt, Vijay Chauthaiwale